Insider Transactions Reported by 12 Insiders of AVADEL PHARMACEUTICALS PLC

Symbol
AVDL on Nasdaq
Location
Dublin 2

There are no Buy or Sell transactions made by insiders since 22 Jan 2025

AVADEL PHARMACEUTICALS PLC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Eric J. Ende Director $2,082,453 29 Jul 2025
Gregory J. Divis Chief Executive Officer, Director $1,752,881 05 Mar 2025
Peter J. Thornton Director $1,089,570 29 Jul 2025
Geoffrey Michael Glass Director $1,031,320 15 Sep 2025
Linda Palczuk Director $851,353 15 Sep 2025
Mark Anthony McCamish Director $843,066 29 Jul 2025
THOMAS S. MCHUGH Chief Financial Officer $795,971 05 Mar 2025
Naseem Amin Director $208,340 29 Jul 2025
Jerad G. Seurer Gen. Counsel & Corp. Secretary $186,268 05 Mar 2025
Douglas J. Williamson Chief Medical Officer 14 Feb 2022
Richard J. Kim Chief Commercial Officer 20 Feb 2024
Susan Rodriguez Chief Operating Officer 13 May 2025

Recent Insider Transactions by Companies or Individuals for AVADEL PHARMACEUTICALS PLC

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.